Actinium Pharmaceuticals
ATNM
#10031
Rank
โ‚ฌ35.16 M
Marketcap
1,12ย โ‚ฌ
Share price
-6.43%
Change (1 day)
-2.35%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -โ‚ฌ33.81 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.09 Million. In 2024 the company made an earning of -โ‚ฌ36.04 Million, an increase over its 2023 earnings that were of -โ‚ฌ44.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ33.81 Million-6.18%
2024 -โ‚ฌ36.04 Million-18.87%
2023 -โ‚ฌ44.42 Million52.24%
2022 -โ‚ฌ29.18 Million36.61%
2021 -โ‚ฌ21.36 Million11.48%
2020 -โ‚ฌ19.16 Million1.46%
2019 -โ‚ฌ18.89 Million-7.37%
2018 -โ‚ฌ20.39 Million-11.46%
2017 -โ‚ฌ23.03 Million10.67%
2016 -โ‚ฌ20.81 Million15.7%
2015 -โ‚ฌ17.99 Million-14.86%
2014 -โ‚ฌ21.12 Million129.19%
2013 -โ‚ฌ9.22 Million-8.55%
2012 -โ‚ฌ10.08 Million
2010 โ‚ฌ0 M-152.15%
2009 -โ‚ฌ0.02 Million-39.8%
2008 -โ‚ฌ0.03 Million120.29%
2007 -โ‚ฌ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-โ‚ฌ31.82 Million-0.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ0.16 M-100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.41 B-1,392.20%๐Ÿ‡บ๐Ÿ‡ธ USA